Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya
SAMI
1 other identifier
interventional
68
2 countries
2
Brief Summary
Reports from the Kenya Red Cross Society (KRCS) in Kwale County, southern Kenya, indicate a limited impact of Ready-to-Use Therapeutic Foods (RUTFs) on malnutrition or anemia. The current RUTF formulation may have an excessively high iron content. In severely acutely malnourished (SAM) children, iron cannot be properly absorbed, leading to life-threatening diarrhea. The overall aim of this project is to develop an improved RUTF treatment that addresses acute malnutrition and anemia in children, ensuring both safety and efficacy. Specifically, to assess the impact of malnutrition on fractional iron absorption (FIA) from RUTFs in children, by comparing healthy children to those with acute malnutrition and by tracking changes in FIA in malnourished children over the course of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2025
CompletedStudy Start
First participant enrolled
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
January 2, 2026
December 1, 2025
6 months
December 18, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fractional Iron Absorption
Day 0
Fractional Iron Absorption
Day 20
Fractional Iron Absorption
Day 40
Fractional Iron Absorption
Day 60
Secondary Outcomes (29)
Hemoglobin
Day 0
Hemoglobin
Day 20
Hemoglobin
Day 40
Hemoglobin
Day 60
Hemoglobin
Day 80
- +24 more secondary outcomes
Study Arms (2)
Healthy children
ACTIVE COMPARATORHealthy children
Children with MAM/SAM
EXPERIMENTALchildren with moderate or severe acute malnutrition
Interventions
Eligibility Criteria
You may qualify if:
- malnourished children:
- severe acute malnutrition (SAM): WHZ \< -3.0
- moderate acute malnutrition (MAM): WHZ \< -2.0 a
- treated as outpatients (no acute medical conditions and a positive appetite test)
- healthy children:
- \- healthy: HAZ, WAZ and WHZ = 0
You may not qualify if:
- Hemoglobin ≤7 g/dL
- Presence of acute medical conditions requiring inpatient management
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ETH Zurichlead
Study Sites (2)
ETH/Oxford/JKUAT research facility
Msambweni, Kwale County, Kenya
ETH Zurich, Laboratory of Clinical Biopharmacy, Zurich, 8092
Zurich, 8006, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistantprofessor
Study Record Dates
First Submitted
December 18, 2025
First Posted
January 2, 2026
Study Start
December 23, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share